From Akili’s transition to over-the-counter to the downfall of Pear Therapeutics, it’s been an exciting time lately in the world of digital therapeutics.
The life sciences industry is embracing the transformative power of artificial intelligence (AI) and automation, leveraging its unmatched advancements in speed, accuracy, and efficiency to
After two FDA rejections for non-alcoholic steatohepatitis (NASH) therapy obeticholic acid (OCA), Intercept Pharma has agreed to be taken over by Italian drugmaker Alfasig
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho
